Clinical Trial Update: Zometa and Circulating Vascular Endothelial Growth Factor (VEGF) in Breast Cancer Patients With Bone Metastasis [Phase 2, Phase 3]

View source ↗

Summary

Phase 2/3 trial update reporting completion of studies evaluating zoledronic acid (Zometa) in breast cancer patients with bone metastases, including analyses re…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Bone Metastases
• Breast Cancer

Drugs mentioned

• Zometa (Zoledronic acid)

Snippet

Sponsor: Fudan University | Conditions: Metastatic Breast Cancer, Bone Metastases | Phase 2, Phase 3 | Status: COMPLETED